People

Dr Michelle Turvey holds a BSc in Biotechnology and a PhD in Microbiology & Immunology from The University of Adelaide, Australia. Her doctoral work was focused on the mechanisms of directed cell migration in metastatic cancer cells and in immune cells during inflammation and autoimmunity. In 2016, she moved to Singapore and joined Paula Hammond’s group at SMART, where she is now responsible for leading a collaborative project between the Hammond Labs based at SMART and MIT, the MBE Chan Lab based at NTU, and investigators at SCELSE and NTU Lee Kong Chian School of Medicine.

Dr Turvey’s research at AMR IRG involves the development of nanoparticle-based drug delivery systems capable of controlled spatio-temporal release of synergistic drug combinations for the treatment of biofilm-associated microbial infections.